Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer
about
Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Genome Wide Association Study ...... f Metastatic Colorectal Cancer
@ast
Genome Wide Association Study ...... f Metastatic Colorectal Cancer
@en
type
label
Genome Wide Association Study ...... f Metastatic Colorectal Cancer
@ast
Genome Wide Association Study ...... f Metastatic Colorectal Cancer
@en
prefLabel
Genome Wide Association Study ...... f Metastatic Colorectal Cancer
@ast
Genome Wide Association Study ...... f Metastatic Colorectal Cancer
@en
P2093
P2860
P921
P1433
P1476
Genome Wide Association Study ...... f Metastatic Colorectal Cancer
@en
P2093
Cornelis Punt
Hans Gelderblom
Jan Pander
Lieke van Huis-Tanja
Stefan Böhringer
Tahar van der Straaten
P2860
P304
P356
10.1371/JOURNAL.PONE.0131091
P407
P577
2015-07-29T00:00:00Z